Menu
+
+
+
+
+
+
Eli Lilly and Co. (NYSE:LLY) discontinued from its pipeline a Bruton's tyrosine kinase (Btk) inhibitor it had licensed from Hanmi Pharmaceutical Co. Ltd. (KSE:128940). The pharma...
BioCentury employs a fully integrated multimedia platform — including publications, online data solutions and conferences — to provide its audience with authoritative and up-to-date intelligence about corporate strategy, partnering, emerging technology, clinical data, public policy and the financial markets.
